New hope for blood cancer patients: experimental combo challenges standard chemo

NCT ID NCT07486479

Summary

This study compares two treatment approaches for adults newly diagnosed with acute myeloid leukemia (AML), a serious blood cancer. Researchers want to see if a new combination of three drugs works better and is safer than the current standard chemotherapy. The trial will enroll 204 participants who will be randomly assigned to receive either the experimental treatment or the standard treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, 226001, China

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, 226001, China

    Contact

    Contact

  • Changzhou First People's Hospital

    Changzhou, Jiangsu, 213003, China

    Contact

  • Huai'an Second People's Hospital

    Huai'an, Jiangsu, 223002, China

    Contact

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, 210029, China

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, 210029, China

    Contact

    Contact

  • Jiangsu Province Hospital of Chinese Medicine

    Nanjing, Jiangsu, 210029, China

    Contact

  • Jingjiang People's Hospital

    Jingjiang, Jiangsu, 214500, China

    Contact

  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, 225001, China

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China

    Contact

  • Shandong First Medical University Affiliated Tumor Hospital

    Jinan, Shandong, China

    Contact

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230022, China

    Contact

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, 41003, China

    Contact

  • The First Affiliated Hospital of Ningbo University

    Ningbo, Zhejiang, 315010, China

    Contact

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215006, China

    Contact

    Contact

  • The First People's Hospital Of Lianyungang

    Lianyungang, Jiangsu, 222002, China

    Contact

  • The Second People's Hospital of Lianyungang

    Lianyungang, Jiangsu, 222006, China

    Contact

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

    Contact

  • Wuxi People's Hospital

    Wuxi, Jiangsu, 214023, China

    Contact

  • YanCheng NO.1 People's Hospital

    Yancheng, Jiangsu, 224006, China

    Contact

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310022, China

    Contact

Conditions

Explore the condition pages connected to this study.